Amazon (AMZN) has just acquired Fauna Robotics, a New York-based startup building humanoid robots for everyday consumers and businesses.

Founded in 2024 by former Meta and Google engineers, Fauna's flagship product is Sprout — a 3.5-foot, 50-pound bipedal robot priced at $50,000, designed to be approachable, human-friendly, and accessible to software developers.

Early customers include Disney and Hyundai's Boston Dynamics. Terms of the deal were not disclosed.

Amazon is no stranger to robotics — it bought Kiva Systems for $775 million back in 2012, which became the foundation of Amazon Robotics.

More recently, Amazon acquired Swiss startup Rivr for doorstep delivery robotics. Fauna's ~50 employees will operate as "Fauna Robotics, an Amazon company" out of New York.

This deal puts Amazon squarely in the humanoid robot race alongside Tesla's Optimus, Figure AI, Agility Robotics, and 1X — a market heating up fast.

AMZN stock has a low Ziggma score of 32, as it ranks lower than its peers in growth and valuation.

However, analysts forecast the e-commerce giant to gain 40% from current levels.

Amazon is making a calculated long-game bet here. Warehouse robotics is Amazon's comfort zone, but consumer humanoids are a different beast altogether — and a $50,000 price tag for Sprout isn't exactly "accessible" yet.

That said, Amazon's retail relationships, device ecosystem (think Alexa, Ring, Astro), and logistics infrastructure give it a real edge in turning robotics from a novelty into a household staple.

The Fauna acquisition signals that Amazon isn't content to let Tesla, Figure AI, or China's Unitree define this category.

Investors should watch how quickly Amazon can bring costs down and whether Sprout integrations appear in the Prime or Alexa ecosystems within 12–18 months.

➡️ FREE ZIGGMA RESEARCH: Saving Lives, Growing Profits: Why Boston Scientific (BSX) Earns a Spot on the GoodStocks List 🔖 Read for free on Substack 🎧 Listen to podcast

Markets reversed course on Tuesday as investors grappled with renewed uncertainty over the U.S.-Iran conflict now in its fourth week.

Oil prices rebounded sharply — Brent crude settled up 4.55% at $104.49/barrel, while WTI rose 4.79% to $92.35/barrel — after a brief Monday sell-off.

President Trump said the U.S. is "in negotiations right now" with Iran, but Iranian state media denied any direct talks, deepening investor confusion.

Israel and Iran continued exchanging strikes despite Trump's optimistic comments, and the Pentagon is reportedly weighing deployment of ~3,000 soldiers to the region.

Energy was the only S&P 500 sector to finish in the green, rising 2% and extending its month-to-date gain beyond 9%.

Meanwhile, the software sector took another beating — the iShares IGV ETF dropped more than 3%, now down 23% in 2026, as fears of AI disruption continued to hammer valuations.

Treasury yields also surged after a "weak" 2-year auction, with the 2-year yield rising above 11 basis points to 3.944%.

Every year, $240B is spent on treating the symptoms of osteoarthritis. But not a single therapy has been able to actually stop it. The answer, it turns out, has been inside us all along.

A startup named Cytonics discovered the human body already produces a protein designed to protect cartilage. It just doesn’t produce enough where it's needed most. So Cytonics harnessed it. 

Their first-generation therapy has already treated 10,000+ patients. Now they've engineered a 200% more potent, mass-producible version pushing toward FDA approval.

If approved, it could be the first therapy to actually halt cartilage destruction and promote regrowth in a market that has never had a real solution. Claim a piece at the pre-clinical stage as an early-stage investor before March 26 to receive time-sensitive investor bonuses.

Invest in Cytonics Now

^{This is a paid advertisement for Cytonics Regulation CF offering. Please read the offering circular at https://cytonics.com/}

Corning was Tuesday's standout performer after BofA Securities issued a bullish upgrade, raising its price target to $155.

The thesis centers on an accelerating optical cycle and surging demand for high-density fiber optic infrastructure as AI data center buildouts expand globally.

BofA's conviction signals that the market may have been underpricing Corning's positioning at the intersection of two major secular themes: AI infrastructure and optical connectivity.

LYB surged as one of the clearest beneficiaries of the oil price spike, with crude jumping $3.67 to $91.80/barrel on Iran-related supply fears.

As a major petrochemical producer, LYB's margins and investor appeal are closely tied to energy input dynamics.

With analysts warning crude could test $200/barrel by June if the Strait of Hormuz remains disrupted, petrochemicals are attracting investors seeking levered exposure to tightening energy supply chains.

Coinbase had a brutal session, cratering nearly 10% as the proposed Clarity Act raised serious concerns about restricting yield on stablecoin balances — a product line that generates an estimated $364 million per quarter in revenue.

The regulatory overhang is real: if yield on stablecoin is curtailed, Coinbase loses one of its most compelling user-retention tools.

While crypto bulls argue this legislative risk will fade, the near-term path for COIN remains clouded by Washington's evolving crypto rulebook.

🤖 Jefferies shares jumped as much as 10% after Japan's Sumitomo Mitsui Financial Group was reported to be preparing a potential takeover bid for the investment bank.

🔴 Circle Internet Group plummeted 19% — its worst day on record — as the proposed Clarity Act threatens to limit yield on stablecoin balances.

🛢️ Six S&P 500 stocks hit all-time highs on Tuesday, all energy names: Chevron, ExxonMobil, Marathon Petroleum, Phillips 66, EQT, and Corteva, as oil prices surged amid the Iran conflict.

🇸🇦 Saudi Arabia and the UAE are reportedly moving closer to joining the fight against Iran, per the Wall Street Journal, with Saudi Crown Prince MBS reportedly near a decision.

🏦 Apollo Global Management will fulfill only 45 cents on the dollar of withdrawal requests from its $15B private credit fund after redemptions hit 11.2% of shares — more than double the 5% quarterly cap.

📉 Moody's downgraded FS KKR Capital Corp (a private credit fund run by KKR and Future Standard) to junk status (Ba1 from Baa3), citing deteriorating asset quality and rising non-accrual loans at 5.5% of total investments.

🏡 Estée Lauder confirmed it is in merger talks with Puig (owner of Charlotte Tilbury and Carolina Herrera), though no final decision has been made. EL shares fell nearly 10% Tuesday.

🛒 Retail investors net-sold stocks for the first time since November 2023, offloading more than $20 million on a net basis Monday, according to VandaTrack, as war-related uncertainty erodes small investor confidence.

⬆️ UBS upgraded JFrog (FROG) to Buy with a $60 price target, citing "overdone" AI disruption risk after the software stock fell 31% since January.

TTD's stock dropped sharply after a third-party audit alleged that the company violated its master service agreement with Publicis Groupe regarding fee applications.

Publicis advised clients to pause using the platform — a significant blow, given that agency holding companies account for ~30% of TTD's spending. Until the situation is resolved, expect elevated volatility in the stock.

CRM was caught in a broad software sell-off despite solid fundamentals, with full-year revenues of $41.53 billion and its Agentforce AI product hitting an $800 million annual run rate.

Macro headwinds and sector rotation away from software dominated on the day. The story remains intact over the long term, but the market is aggressively repricing all software names in 2026.

Dell recovered strongly from recent macro-driven weakness, benefiting from sustained demand for AI data center infrastructure and investor rotation into hardware names. A $74.6 million insider stock sale was largely shrugged off.

With geopolitical premiums building into server infrastructure plays, Dell continues to be a key beneficiary.

📦 PDD Holdings reports Q4 2025 earnings before market open — watch for revenue growth signals in e-commerce.

👔 Cintas Corporation (CTAS) Q3 2026 results before open — a reliable employment health barometer.

💼 Paychex (PAYX) Q3 2026 earnings before open — key read on small business health and wage inflation.

🐾 Chewy (CHWY) Q4 2025 report before market open — consumer spending and e-commerce demand in focus.

🛢️ Strait of Hormuz remains closed — Brent crude volatility will persist; energy stocks stay in focus.

🏠 MBA Mortgage Applications data due — will reveal how rate uncertainty is cooling the housing market.

📊 Fed Rate Watch — markets continue to digest the Fed's decision to hold rates at 3.50%–3.75%, with core PCE at 3.1%.

📉 Q4 GDP revision of just +0.7% is fueling recession concerns — expect continued rotation toward defensive sectors.

Ready to analyze your portfolio's exposure across sectors? Explore Ziggma's advanced portfolio optimization tools to position for the week ahead >>>.

Great investing starts with great information.

Forward The Market Scoop to anyone who wants to stay ahead of the market through a pertinent and entertaining newsletter format.

Don’t follow us on social yet? Follow us on Twitter and LinkedIn now.

DISCLAIMER: None of this is financial advice. The newsletter is strictly educational and is not investment advice or a solicitation to buy or sell assets or make financial decisions. Please exercise caution and conduct your own research.